ArticleClinical and molecular hepatology2026

Berberine and the gut microbiota - A novel treatment strategy for cholestatic liver disease: Editorial on "Gut microbiota-mediated berberine metabolism ameliorates cholestatic liver disease by suppressing 5-hydroxytryptamine production".

Sung-Min Won et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.